Josh Arnold Investment Consultant, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Josh Arnold Investment Consultant, LLC reported 10 stock positions worth $95.1 million. Its top holding was Apple (AAPL) at 64.0% of the portfolio, followed by Amazon.com (AMZN, 22.5%) and Donnelley Financial Solution (DFIN, 5.5%). Compared with Q4 2023, it opened 5 new positions, sold out of 13, added to 2 and reduced 2. The biggest buy was a new position in Donnelley Financial Solution (DFIN) and the biggest sale Apple (AAPL, shares −3%).
- Most Recent 13F
- Q2 2026
- Location
- EDINA, MN
- CIK
- 0001911348
- Portfolio Value
- $95.1M (Q1 2024)
- SEC Filing
- 0001911348-24-000002 ↗ filed May 15, 2024
Holdings Value
Holdings 10 stocks · $95.1M
| AAPL Apple Inc. | 64.00% | 354,899 | $60.9M | Reduce -2.6% |
| AMZN Amazon.com Inc. | 22.54% | 118,797 | $21.4M | Reduce -0.2% |
| DFIN Donnelley Financial Solution | 5.47% | 83,925 | $5.2M | New |
| EVH Evolent Health Inc. Class A | 4.14% | 120,000 | $3.9M | New |
| EXPE Expedia Group Inc. | 1.52% | 10,500 | $1.4M | Add +202.2% |
| XYZ Block Inc. | 0.91% | 10,275 | $869K | New |
| MSFT Microsoft Corp. | 0.55% | 1,242 | $523K | Add +73.2% |
| WFC Wells Fargo & Co. | 0.37% | 6,000 | $348K | No change |
| DIA SS SPDR Dow Jones Indus Avg filed as SPDR DOW JONES INDL AVERAGE | 0.28% | 678 | $270K | New |
| PSX Phillips 66 | 0.21% | 1,250 | $204K | New |
Portfolio Sells Q4 2023 → Q1 2024
| AAPL Apple Inc. | Reduce -2.6% | 64.00% | −3.97 |
| STLN Starling Oncology Inc. | Sold out | 0.00% | −3.67 |
| PAGAYA TECHNOLOGIES LTD | Sold out | 0.00% | −2.08 |
| DKNG Draftkings Inc. Class A | Sold out | 0.00% | −1.39 |
| PENN Penn Entertainment Inc. | Sold out | 0.00% | −1.29 |
| ABNB Airbnb Inc. Class A | Sold out | 0.00% | −1.29 |
| CZR Caesars Entertainment Inc. | Sold out | 0.00% | −1.22 |
| LPRO Open Lending Corp. | Sold out | 0.00% | −0.70 |
| BRK.B Berkshire Hathaway Inc. Class B | Sold out | 0.00% | −0.39 |
| RQI Cohen & Steers Qual Inc. RLTY | Sold out | 0.00% | −0.38 |
| CLBT Cellebrite Di Ltd. | Sold out | 0.00% | −0.34 |
| BKD Brookdale Senior Living Inc. | Sold out | 0.00% | −0.25 |
| FLAME ACQUISITION CORP | Sold out | 0.00% | −0.23 |
| EVLV Evolv Technologies Holdings | Sold out | 0.00% | −0.21 |
| AMZN Amazon.com Inc. | Reduce -0.2% | 22.54% | +5.01 |
Portfolio Buys Q4 2023 → Q1 2024
| DFIN Donnelley Financial Solution | New | 5.47% | +5.47 |
| EVH Evolent Health Inc. Class A | New | 4.14% | +4.14 |
| EXPE Expedia Group Inc. | Add +202.2% | 1.52% | +1.01 |
| XYZ Block Inc. | New | 0.91% | +0.91 |
| MSFT Microsoft Corp. | Add +73.2% | 0.55% | +0.29 |
| DIA SS SPDR Dow Jones Indus Avg | New | 0.28% | +0.28 |
| PSX Phillips 66 | New | 0.21% | +0.21 |
Notes & Other Activity Q4 2023 → Q1 2024
| CLBTW Cellebrite Di Ltd. -CW23 | *W EXP 99/99/999 | Sold out | 871,889 | $1.2Mbefore exit |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | Sold out | 559,843 | $123Kbefore exit |
| HUMAW Humacyte Inc.-CW27 | *W EXP 08/27/202 | Sold out | 259,974 | $108Kbefore exit |
| STLNW Oncology Institute Inc. CW-22 | *W EXP 99/99/999 | Sold out | 417,745 | $63Kbefore exit |
| CMXWQ Caremax-CW | *W EXP 06/08/202 | Sold out | 122,044 | $915before exit |
| CANWQ Cano Health Inc.-CW25 | *W EXP 06/03/202 | Sold out | 363,132 | $254before exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 21 | $159.0M | AAPL, AMZN, STLN, AGL, PRCH |
| Q1 2026 | 13 | $117.0M | AAPL, AMZN, STLN, TKO, PLTR |
| Q4 2025 | 15 | $134.0M | AAPL, AMZN, STLN, PLTR, TKO |
| Q3 2025 | 13 | $124.1M | AAPL, AMZN, TKO, PLTR, LYV |
| Q2 2025Amended | 14 | $115.2M | AAPL, AMZN, STLN, TKO, PLTR |
| Q1 2025 | 19 | $120.2M | AAPL, AMZN, LYV, AIOT, TKO |
| Q4 2024 | 11 | $118.2M | AAPL, AMZN, TKO, PLTR, NVDL |
| Q3 2024 | 24 | $121.6M | AAPL, AMZN, NVDA, AIOT, DKNG |
| Q2 2024 | 17 | $116.1M | AAPL, AMZN, DKNG, AIOT, CNS |
| Q1 2024 | 10 | $95.1M | AAPL, AMZN, DFIN, EVH, EXPE |